| Literature DB >> 32079323 |
Rossella Gratton1,2, Paola Maura Tricarico1, Almerinda Agrelli3,4, Heverton Valentim Colaço da Silva3,4, Lucas Coêlho Bernardo3,4, Sergio Crovella1,5, Antonio Victor Campos Coelho6, Ronald Rodrigues de Moura4,5, Lucas André Cavalcanti Brandão3,4.
Abstract
The Zika virus (ZIKV) is an emergent arthropod-borne virus (arbovirus) responsible for congenital Zika syndrome (CZS) and a range of other congenital malformations. Evidence shows that ZIKV infects human neural progenitor cells (hNPCs) in the fetal brain, prompting inflammation and tissue damage/loss. Despite recent advances, little is known about the pathways involved in CZS pathogenesis. We performed a meta-analysis, gene ontology (GO), and pathway analysis of whole transcriptome studies with the aim of clarifying the genes and pathways potentially altered during hNPCs infection with ZIKV. We selected three studies (17 samples of infected hPNCs compared to hPNCs uninfected controls) through a systematic search of the Gene Expression Omnibus (GEO) database. The raw reads were trimmed, counted, and normalized. Next, we performed a rank product meta-analysis to detect consistently differentially expressed genes (DEGs) in these independent experiments. We detected 13 statistically significant DEGs. GO ontology and reactome analysis showed an enrichment of interferon, pro-inflammatory, and chemokines signaling and apoptosis pathways in ZIKV-infected cells. Moreover, we detected three possible new candidate genes involved in hNPCs infection: APOL6, XAF1, and TNFRSF1. Our results confirm that interferon (IFN) signaling dominates the ZIKV response, and that a crucial contribution is given by apoptotic pathways, which might elicit the CZS phenotype.Entities:
Keywords: apoptosis; congenital Zika syndrome; gene ontology; genomics; pathway analysis; stem cells; transcriptomics
Year: 2020 PMID: 32079323 PMCID: PMC7074932 DOI: 10.3390/microorganisms8020270
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Detailed information regarding the three selected studies that matched the study criteria. DEGs: differentially expressed genes, hiPSCs (human-induced pluripotent stem cells), MOI (multiplicity of infection), NPCs (neural progenitor cells), RNA-Seq (RNA sequencing), ZIKV (Zika virus).
| SRA | Title | Samples | Replicates | Main Results |
|---|---|---|---|---|
| SRP073493 | Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors [ | Three infected (two with African and one with Asian lineage); two non-infected | Two per sample | The RNA-Seq extraction was gone in 56 hpi for African lineage and 64 hpi for Asian lineage. MOI of 0.2 and 0.4. DEGs include |
| SRP096367 | Differential Responses of Human Fetal Brain Neural Stem Cells to Zika Virus Infection [ | Three infected with Asian or African lineage; three non-infected | Three per sample | Usage of isolates from Mexico (Asian lineage), Cambodia (Asian lineage), and Senegal strains (African lineage). Following 120 hpi to RNA-Seq extraction. MOI of 0.1 and 1. The DEGs found were |
| SRP114529 | RNA-seq of hiPSCs-Derived NPCs from Three Pairs of Dizygotic Discordant Twins for Congenital Zika Syndrome [ | Three infected with Asian lineage; three non-infected | One per sample | Brazilian strain (Asian lineage) used at a MOI of 0.01 and 0.1. RNA-Seq extracted 96 hpi. Indentified DEGs included |
Meta-analysis results of three RNA-Seq assays involving human neural stem cells experimentally infected in vitro with Zika virus when compared to control cells, ranked by lowest p-values corrected by the percentage of false prediction, pfp (rank product test).
| Gene | Rank Product | Fold Change | log2 (Fold Change) | pfp | |
|---|---|---|---|---|---|
| (Control/ZIKV-Infected) | |||||
|
| 334.5 | 0.228 | −2.1329 | 1.874 × 10−9 | 0.0001 |
|
| 350.9 | 0.3021 | −1.7269 | 2.664 × 10−9 | 0.00004 |
|
| 840.8 | 0.3739 | −1.4193 | 0.000001 | 0.0088 |
|
| 880.8 | 0.2667 | −1.9067 | 0.000002 | 0.0095 |
|
| 997.5 | 0.1634 | −2.6135 | 0.000004 | 0.0153 |
|
| 1001 | 0.2218 | −2.1727 | 0.000004 | 0.0137 |
|
| 1085 | 0.2048 | −2.2877 | 0.000006 | 0.0205 |
|
| 1150 | 0.3442 | −1.5387 | 0.000009 | 0.0266 |
|
| 1158 | 0.3843 | −1.3797 | 0.00001 | 0.0254 |
|
| 1164 | 0.3466 | −1.5287 | 0.00001 | 0.0241 |
|
| 1203 | 0.1532 | −2.7065 | 0.00001 | 0.0273 |
|
| 1251 | 0.283 | −1.8213 | 0.00002 | 0.0323 |
|
| 1314 | 0.4441 | −1.1710 | 0.00002 | 0.0383 |
List of 20 gene ontology (GO) terms that were enriched in the meta-analysis of three RNA-Seq assays involving human neural stem cells that were experimentally infected in vitro with Zika virus when compared to control cells (false discovery rate (FDR)-adjusted p-values). The complete list of all 847 terms can be found in Supplementary Table S1.
| Rank | GO Term | Genes in GO Term | Genes of GO Term Present in Data | Adjusted | GO Term Description |
|---|---|---|---|---|---|
| 23 | GO:0043066 | 541 | 526 | 0.00071 | Negative regulation of apoptotic process |
| 49 | GO:0009615 | 109 | 109 | 0.00570 | Response to virus |
| 57 | GO:0006915 | 693 | 666 | 0.00617 | Apoptotic process |
| 64 | GO:0016032 | 476 | 460 | 0.00662 | Viral process |
| 69 | GO:0033209 | 118 | 117 | 0.00749 | Tumor necrosis factor-mediated signaling pathway |
| 125 | GO:1902237 | 11 | 11 | 0.01385 | Positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
| 132 | GO:1901216 | 41 | 41 | 0.01523 | Positive regulation of neuron death |
| 142 | GO:0050727 | 81 | 81 | 0.01576 | Regulation of inflammatory response |
| 152 | GO:0006954 | 386 | 372 | 0.01612 | Inflammatory response |
| 257 | GO:0006959 | 56 | 56 | 0.02419 | Humoral immune response |
| 282 | GO:0043065 | 375 | 360 | 0.02500 | Positive regulation of apoptotic process |
| 328 | GO:0051607 | 201 | 195 | 0.02596 | Defense response to virus |
| 546 | GO:0042771 | 29 | 29 | 0.03671 | Intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| 570 | GO:0034612 | 32 | 32 | 0.03800 | Response to tumor necrosis factor |
| 576 | GO:0002523 | 9 | 9 | 0.03854 | Leukocyte migration involved in inflammatory response |
| 639 | GO:0097194 | 18 | 18 | 0.04256 | Execution phase of apoptosis |
| 641 | GO:0045089 | 25 | 25 | 0.04259 | Positive regulation of innate immune response |
| 683 | GO:0002741 | 8 | 8 | 0.04391 | Positive regulation of cytokine secretion involved in immune response |
| 704 | GO:0002437 | 15 | 15 | 0.04585 | Inflammatory response to antigenic stimulus |
| 805 | GO:0002827 | 9 | 9 | 0.04832 | Positive regulation of T-helper 1 type immune response |
A list of “reactome” pathways that were enriched in the meta-analysis of three RNA-Seq assays involving human neural stem cells experimentally infected in vitro with Zika virus when compared to control cells. FADD/RIP-1 (fas-associated death domain and receptor interacting protein 1), GPCR (G protein-coupled receptor), IFN (interferon), IRF (interferon regulatory factor), NF-kB (nuclear factor kappa B), TRAF3 (tumor necrosis factor receptor-associated factor 3).
| Reactome ID | Description | Adjusted | Gene Symbols | |
|---|---|---|---|---|
| R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 6.50 × 10−5 | 0.0005 |
|
| R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) | 0.0039 | 0.0135 |
|
| R-HSA-375276 | Peptide ligand-binding receptors | 0.0008 | 0.0039 |
|
| R-HSA-380108 | Chemokine receptors bind chemokines | 1.39 × 10−5 | 0.0002 |
|
| R-HSA-418594 | G alpha (i) signaling events | 0.0073 | 0.0228 |
|
| R-HSA-500792 | GPCR ligand binding | 0.0101 | 0.0282 |
|
| R-HSA-6783783 | Interleukin-10 signaling | 0.0010 | 0.0041 |
|
| R-HSA-877300 | Interferon gamma signaling | 9.87 × 10−5 | 0.0005 |
|
| R-HSA-909733 | Interferon alpha/beta signaling | 5.21 × 10−7 | 1.46 × 10−5 |
|
| R-HSA-913531 | Interferon Signaling | 3.56 × 10−5 | 0.0003 |
|
| R-HSA-918233 | TRAF3-dependent IRF activation pathway | 0.0144 | 0.0336 |
|
| R-HSA-933543 | NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 0.0127 | 0.0315 |
|
Figure 1Meta-analysis of RNA-Seq assays for the characterization of congenital Zika syndrome (CZS). ZIKV can infect hNPCs in the fetal brain, possibly leading to congenital malformations. Despite recent advances, the characterization of the main cellular pathways involved in the anti-ZIKV response are yet not fully understood and clearly constitute a limitation for the development of therapeutic approaches that could prevent the severe clinical consequences of the infection. By performing a meta-analysis, gene ontology, and reactome pathway analysis of whole transcriptome studies, we aimed at clarifying the genes and pathways that are potentially altered during hNPCs infection with ZIKV. Our results led to the identification of 13 DEGs found to be upregulated in hNPCs infected by ZIKV. Specifically, we detected three possible new candidate genes, never previously associated to ZIKV-infection, expressed during the antiviral response in infected hPNCs: APOL6, XAF1, and TNFRSF1. Finally, we have confirmed that INF signaling dominates the response against ZIKV infection and that an important contribution is given by apoptotic pathways that might elicit the CZS phenotype.